An interventional study of PRP in Erectile Dysfunction and PRP, sponsored by National Taiwan University Hospital. Status unknown at 1 site in Taiwan. Open to male participants aged 20 Years to 70 Years. Per ClinicalTrials.gov, last updated 2022-02-16.
Sponsored by National Taiwan University Hospital · Not applicable, Interventional, and Treatment
RPR contains rich-in growth factors and has the properties of helping tissue regeneration and nerve repair. In theory, it is possibility of curing ED.
There are many reasons of erectile dysfunction(ED). If left untreated, there is a major impact on relationships, self-esteem, and overall health. RPR contains rich-in growth factors and has the properties of helping tissue regeneration and nerve repair. Its mechanism is to promote the regeneration of blood vessels in the cavernous body of the penis, increase blood circulation, and then help erection, increase penile stiffness and improve the phenomenon of premature ejaculation. The main purpose of this study is to study the safety and effectiveness of PRP injection for the treatment of ED.
683 studies on the registry are indexed under Erectile Dysfunction; 117 are open to participants now.
This study's planned enrollment of 30 is below the median of 72 across 542 interventional studies indexed under Erectile Dysfunction.
Browse Erectile Dysfunction studies →National Taiwan University Hospital is the lead sponsor of 2,563 studies on the registry; 569 are open to participants now.
Of its 11 completed or terminated interventional studies of FDA-regulated products, 2 (18%) have results posted.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
PRP injection
Biological: PRP
4\~6ml autologous platelet rich plasma injection every 14±2 days for a total of 5 injections.
International Index of Erectile Function(IIEF-5)
The possible scores for the IIEF-5 range from 5 to 25, and ED was classified into five categories based on the scores: severe (5-7), moderate (8-11), mild (12-21), and no ED (22-25).
Time frame: Change from 0 week at 4,8,12,24,48 weeks
Erection Hardness Score(EHS)
EHS can be a helpful tool to evaluate ED - a man's inability to get or maintain an erection firm enough for sex. To select one of the following options: 0 Penis does not enlarge 1. Penis is larger, but not hard 2. Penis is hard, but not hard enough for penetration 3. Penis is hard enough for penetration, but not completely hard 4. Penis is completely hard and fully rigid
Time frame: Change from 0 week at 4,8,12,24,48 weeks
Duplex - Peak systolic velocity(PSV)
To assess penile hemodynamics - Penile arterial blood velocity record (cm/s)
Time frame: 0,16 weeks
Duplex - Resistance index(RI)
To assess penile hemodynamics - Penile vascular resistance Index
Time frame: 0,16 weeks
This study is status unknown, as verified in Sep 2021. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
National Taiwan University Hospital